Less Severe Cases of COVID-19 in Sub-Saharan Africa: Could Co-infection or a Recent History of Plasmodium falciparum Infection Be Protective?

Front Immunol. 2021 Feb 18:12:565625. doi: 10.3389/fimmu.2021.565625. eCollection 2021.

Abstract

Sub-Saharan Africa has generally experienced few cases and deaths of coronavirus disease 2019 (COVID-19). In addition to other potential explanations for the few cases and deaths of COVID-19 such as the population socio-demographics, early lockdown measures and the possibility of under reporting, we hypothesize in this mini review that individuals with a recent history of malaria infection may be protected against infection or severe form of COVID-19. Given that both the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Plasmodium falciparum (P. falciparum) merozoites bind to the cluster of differentiation 147 (CD147) immunoglobulin, we hypothesize that the immunological memory against P. falciparum merozoites primes SARS-CoV-2 infected cells for early phagocytosis, hence protecting individuals with a recent P. falciparum infection against COVID-19 infection or severity. This mini review therefore discusses the potential biological link between P. falciparum infection and COVID-19 infection or severity and further highlights the importance of CD147 immunoglobulin as an entry point for both SARS-CoV-2 and P. falciparum into host cells.

Keywords: COVID-19; Plasmodium falciparum infection; SARS–CoV-2; Sub-Saharan Africa; co-infection.

Publication types

  • Review

MeSH terms

  • Africa South of the Sahara / epidemiology
  • Basigin / immunology*
  • COVID-19* / epidemiology
  • COVID-19* / immunology
  • Humans
  • Immunologic Memory*
  • Malaria, Falciparum* / epidemiology
  • Malaria, Falciparum* / immunology
  • Merozoites / immunology
  • Plasmodium falciparum / immunology*
  • SARS-CoV-2 / immunology*
  • Severity of Illness Index

Substances

  • BSG protein, human
  • Basigin